Atara Biotherapeutics
ATRA
ATRA
74 hedge funds and large institutions have $695M invested in Atara Biotherapeutics in 2015 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 38 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
40% more funds holding
Funds holding: 53 → 74 (+21)
60% less call options, than puts
Call options by funds: $543K | Put options by funds: $1.36M
Holders
74
Holding in Top 10
2
Calls
$543K
Puts
$1.36M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$16M | |
| 3 | +$8.2M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.19M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$6M | |
| 3 | -$2.64M | |
| 4 |
Citigroup
New York
|
-$1.32M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.04M |